Cerebrospinal fluid tau protein is increased in neurosyphilis: A discrimination from syphilis without nervous system involvement?

Sexually Transmitted Diseases

Volumn 34, Issue 4, 2007, Pages 220-223

  Paraskevas, George P ^a   Kapaki, Elisabeth ^a   Kararizou, Evangelia ^a   Mitsonis, Charalampos ^a   Sfagos, Constantinos ^a   Vassilopoulos, Demetris ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUROSYPHILIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY; SYPHILIS;

ADULT; ALZHEIMER DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSYPHILIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SYPHILIS; TAU PROTEINS;

EID: 34247196248     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000233738.23278.4e     Document Type: Article

References (19)

1. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004; 75:1727-1730.
2. Lair L, Naidech AM. Modern neuropsychiatric presentation of neurosyphilis. Neurology 2004; 63:1331-1333.
3. Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. Eur J Neurol 2000; 7:133-144.
4. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143-1153.
5. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997; 46:1-55.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51:1-43.
7. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003; 2:605-613.
8. Paraskevas GP, Kapaki E, Liappas I, et al. The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. J Geriatr Psychiatry Neurol 2005; 18:163-173.
9. Hesse C, Rosengren L, Andreasen N, et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 2001; 297:187-190.
10. Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E. Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD: A discrimination from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2001; 71:401-403.
11. Sobów T, Flirski M, Liberski PP. Amyloid-beta and tau-proteins as biochemical markers of Alzheimer's disease. Acta Neurobiol Exp 2004; 64:53-70.
12. Goh BT, van Voorst Vader PC. European guidelines for the management of syphilis. Int J STD AIDS 2001; 12(suppl 3):14-26.
13. Folstein M, Folstein S, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12:189-198.
14. MacKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944.
15. Kapaki E, Paraskevas GP, Zalonis I, Zournas C. CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis: Discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 2003; 10:119-128.
16. Adams RD, Victor M, Ropper AH, eds. Principles of Neurology, 8th ed. New York: McGraw-Hill Co, 2000:722-728.
17. Wolters EC, Hische EA, Tutuarima JA, et al. Central nervous system involvement in early and late syphilis: The problem of asymptomatic neurosyphilis. J Neurol Sci 1988; 88:229-239.
18. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group Consensus Report of the Working Group on 'Molecular and Biochemical Markers of Alzheimer's Disease.' Neurobiol Aging 1998; 19:109-116.
19. Luger AF, Schmidt BL, Kaulich M. Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS 2000; 11:224-234.